Inhibition of autophagy via 3-methyladenine alleviates the progression of preeclampsia
Acta Biochimica et Biophysica Sinica · 2025
DOI: 10.3724/abbs.2024096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2025. Verfasst von Fei Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, Ningxia Medical University, Yinchuan 750004, China. Hauptthemen laut MEDLINE: Pre-Eclampsia, Autophagy, Adenine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Autophagy is a cellular mechanism for self-renewal that involves the breakdown of cytoplasmic proteins or organelles within lysosomes. Although preeclampsia (PE) exhibits several characteristics that could imply disrupted autophagy, there is limited evidence supporting the notion that impaired placental autophagy directly causes PE, as indicated by differential expression profiling of whole placental tissue. In this study, we aim to explore the significance of autophagy in maintaining pregnancy and its association with PE. First, the RNA-seq results show that 218 genes are differentially expressed in placentas from preeclamptic pregnancies. Notably, KEGG pathway analysis reveals significant enrichment of genes related to autophagy-related signaling pathways, including the PI3K-Akt signaling pathway, the AMPK signaling pathway, and the mTOR signaling pathway. Additionally, our findings indicate an increase in autophagy in placentas from pregnancies complicated by preeclampsia as well as in trophoblasts subjected to hypoxic conditions. Next, we examine the impact of 3-methyladenine (3-MA), a targeted inhibitor of autophagy, on the progression of PE. The administration of 3-MA profoundly alleviates the severity of PE-like symptoms in rats subjected to reduced uterine perfusion pressure (RUPP). The findings from our study suggest that inhibiting autophagy may serve as a promising approach for adjuvant chemotherapy for PE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, Ningxia Medical University, Yinchuan 750004, China.
- School of Basic Medical Sciences, Ningxia Medical University, Yinchuan 750004, China.
- Department of Clinical Medicine, Ningxia Medical University, Yinchuan 750004, China.
- General Hospital of Ningxia Medical University, Yinchuan 750004, China.
- Ningxia Key Laboratory of Vascular Injury and Repair Research, Ningxia Medical University, Yinchuan 750004, China.
- Department of Medical Genetics, Maternal and Child Health of Hunan Province, Changsha 410008, China.
Zitieren
APA
Ma, F., Ding, N., Xie, L., Zhao, X., Ma, S., Li, G., Hao, Y., Xiong, J., Wu, K., Jiang, Y., & Zhang, H. (2025). Inhibition of autophagy via 3-methyladenine alleviates the progression of preeclampsia. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024096
Vancouver
Ma F, Ding N, Xie L, Zhao X, Ma S, Li G, et al. Inhibition of autophagy via 3-methyladenine alleviates the progression of preeclampsia. Acta Biochimica et Biophysica Sinica. 2025. doi:10.3724/abbs.2024096
BibTeX
@article{Ma2025,
author = {Ma, Fei and Ding, Ning and Xie, Lin and Zhao, Xiangyu and Ma, Shengchao and Li, Guizhong and Hao, Yinju and Xiong, Jiantuan and Wu, Kai and Jiang, Yideng and Zhang, Huiping},
title = {Inhibition of autophagy via 3-methyladenine alleviates the progression of preeclampsia},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2025},
doi = {10.3724/abbs.2024096}
}
EUVIMED